Systematic review / meta-analysis 2019
Original English research record

The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.

BMC health services research

Original abstract

Abstract

Background In order to address the opioid crisis in North America, many regions have adopted preventative strategies, such as prescription drug monitoring programs (PDMPs). PDMPs aim to increase patient safety by certifying that opioids are prescribed in appropriate quantities. We aimed to synthesize the literature on changes in opioid-related harms and consequences, an important measure of PDMP effectiveness.

Methods We completed a systematic review. We conducted a narrative synthesis of opioid-related harms and consequences from PDMP implementation. Outcomes were grouped into categories by theme: opioid dependence, opioid-related care outcomes, opioid-related adverse events, and opioid-related legal and crime outcomes.

Results We included a total of 22 studies (49 PDMPs) in our review. Two studies reported on illicit and problematic use but found no significant associations with PDMP status. Eight studies examined the association between PDMP status and opioid-related care outcomes, of which two found that treatment admissions for prescriptions opioids were lower in states with PDMP programs (p

Conclusion Our study found limited evidence to support overall associations between PDMPs and reductions in opioid-related consequences. However, this should not detract from the value of PDMPs' larger role of improving opioid prescribing.

Authors and publication

Rhodes E, Wilson M, Robinson A, Hayden JA, Asbridge M.

Journal
BMC health services research
Publication year
2019
DOI
10.1186/s12913-019-4642-8
Open the full source
This abstract is for information and research. It is not medical advice, a diagnosis or a treatment recommendation.